Author
Listed:
- Matija Snuderl
(NYU Langone Health
NYU Langone Health
NYU Langone Health
NYU Langone Health)
- Kasthuri Kannan
(NYU Langone Health
NYU Langone Health)
- Elke Pfaff
(Hopp Children’s Cancer Center at the NCT Heidelberg (KiTZ)
German Cancer Research Center (DKFZ)
Department of Pediatric Oncology, Hematology & Immunology, Heidelberg, University Hospital)
- Shiyang Wang
(Division of Pediatric Hematology/Oncology, NYU Langone Health)
- James M. Stafford
(Department of Biochemistry and Molecular Pharmacology, NYU Langone Health)
- Jonathan Serrano
(Genome Technology Center, NYU Langone Health)
- Adriana Heguy
(NYU Langone Health
NYU Langone Health
Genome Technology Center, NYU Langone Health)
- Karina Ray
(Genome Technology Center, NYU Langone Health)
- Arline Faustin
(NYU Langone Health
NYU Langone Health)
- Olga Aminova
(Genome Technology Center, NYU Langone Health)
- Igor Dolgalev
(NYU Langone Health
Genome Technology Center, NYU Langone Health)
- Stacie L. Stapleton
(Cancer and Blood Disorders Institute)
- David Zagzag
(NYU Langone Health
NYU Langone Health
Department of Neurosurgery, NYU Langone Health)
- Luis Chiriboga
(NYU Langone Health)
- Sharon L. Gardner
(NYU Langone Health
Division of Pediatric Hematology/Oncology, NYU Langone Health)
- Jeffrey H. Wisoff
(Department of Neurosurgery, NYU Langone Health
Division of Pediatric Neurosurgery, NYU Langone Health)
- John G. Golfinos
(Department of Neurosurgery, NYU Langone Health)
- David Capper
(University of Heidelberg
German Cancer Research Center (DKFZ)
Charité — Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neuropathology)
- Volker Hovestadt
(German Cancer Research Center (DKFZ))
- Marc K. Rosenblum
(Memorial Sloan Kettering Cancer Center)
- Dimitris G. Placantonakis
(Cancer and Blood Disorders Institute
Neuroscience Institute and Kimmel Center for Stem Cell Biology, NYU Langone Health)
- Sarah E. LeBoeuf
(NYU Langone Health)
- Thales Y. Papagiannakopoulos
(NYU Langone Health)
- Lukas Chavez
(German Cancer Research Center (DKFZ))
- Sama Ahsan
(Johns Hopkins Hospital)
- Charles G. Eberhart
(Johns Hopkins Hospital)
- Stefan M. Pfister
(Hopp Children’s Cancer Center at the NCT Heidelberg (KiTZ)
German Cancer Research Center (DKFZ)
Department of Pediatric Oncology, Hematology & Immunology, Heidelberg, University Hospital)
- David T. W. Jones
(Hopp Children’s Cancer Center at the NCT Heidelberg (KiTZ)
German Cancer Research Center (DKFZ))
- Matthias A. Karajannis
(Memorial Sloan Kettering Cancer Center)
Abstract
Pineoblastoma is a rare and highly aggressive brain cancer of childhood, histologically belonging to the spectrum of primitive neuroectodermal tumors. Patients with germline mutations in DICER1, a ribonuclease involved in microRNA processing, have increased risk of pineoblastoma, but genetic drivers of sporadic pineoblastoma remain unknown. Here, we analyzed pediatric and adult pineoblastoma samples (n = 23) using a combination of genome-wide DNA methylation profiling and whole-exome sequencing or whole-genome sequencing. Pediatric and adult pineoblastomas showed distinct methylation profiles, the latter clustering with lower-grade pineal tumors and normal pineal gland. Recurrent variants were found in genes involved in PKA- and NF-κB signaling, as well as in chromatin remodeling genes. We identified recurrent homozygous deletions of DROSHA, acting upstream of DICER1 in microRNA processing, and a novel microduplication involving chromosomal region 1q21 containing PDE4DIP (myomegalin), comprising the ancient DUF1220 protein domain. Expresion of PDE4DIP and DUF1220 proteins was present exclusively in pineoblastoma with PDE4DIP gain.
Suggested Citation
Matija Snuderl & Kasthuri Kannan & Elke Pfaff & Shiyang Wang & James M. Stafford & Jonathan Serrano & Adriana Heguy & Karina Ray & Arline Faustin & Olga Aminova & Igor Dolgalev & Stacie L. Stapleton &, 2018.
"Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma,"
Nature Communications, Nature, vol. 9(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05029-3
DOI: 10.1038/s41467-018-05029-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-05029-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.